Loading...
XNZE
EBO
Market cap3.34bUSD
Nov 13, Last price  
29.05NZD
Name

EBOS Group Ltd

Chart & performance

D1W1MN
XNZE:EBO chart
P/E
22.37
P/S
0.37
EPS
1.05
Div yield, %
6.20%
Shrs. gr., 5y
4.75%
Rev. gr., 5y
5.36%
Revenues
12.84b
+5.25%
306,998,0001,089,169,0001,340,927,0001,370,899,0001,340,977,0001,426,515,0001,540,782,6835,757,234,0006,068,080,0007,101,455,0007,625,854,0007,609,488,0007,250,847,0009,381,933,0009,888,134,00011,451,868,00013,317,446,00014,411,117,00012,195,967,40512,836,725,966
Net income
214m
+0.21%
10,319,00016,663,00019,727,00023,437,00031,579,00027,949,00023,838,08492,069,000105,941,000126,997,000132,846,000149,564,000144,068,000173,946,000199,094,000216,152,000275,735,000296,710,000213,894,011214,334,658
CFO
332m
-20.18%
7,254,00028,546,00033,310,00041,813,00021,703,00028,112,00026,415,000114,152,000133,789,000224,122,000143,943,000176,171,000124,024,900245,308,787320,526,485275,791,107425,917,945376,436,321416,083,099332,102,742
Dividend
Aug 26, 20260.63671 NZD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Related entities

Subsidiaries (4)
EBOS FINANCE AUSTRALIA PTY LTD
EBOS FINANCE NZ LIMITED
EBOS GROUP AUSTRALIA PTY LIMITED
Symbion Pty Ltd

Key people

Adam Hall
Chief Executive Officer · since 2025
Alistair Gray
Chief Financial Officer · since 2024
Brett Barons
Chief Executive Officer - Symbion · since 2018
Kristine James
Chief Executive Officer - Medical Technology · since 2025
Grant Viney
Chief Executive Officer - Animal Care · since 2025
Mithran Naiker
Chief Information Officer · since 2023
Janelle Cain
General Counsel · since 2015
Simon Bunde
Executive General Manager Strategic Operations, ESG and Innovation · since 2022
David Lewis
Executive General Manager · since 2023
Martin Krauskopf
Chief Strategy and Corporate Development Officer · since 2025
Jacinta McCarthy
Executive General Manager - Human Resources · since 2025
Matthew Muscio
Non-Executive Director · since 2025
Independent Non-Executive Chairman of the Board · since 2019
Non-Executive Independent Director · since 2021
Non-Executive Independent Director · since 2022
Non-Executive Independent Director · since 2025
Non-Executive Independent Director · since 2019
Non-Executive Independent Director · since 2023
IPO date
Jun 16, 1986
Employees
5,000
Domiciled in
NZ
Incorporated in
NZ
Headquarters & legal address
108 Wrights Road
Christchurch, CAN 8024
NZ
Trading name
EBOS Healthcare

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT